Stay updated on Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.

Latest updates to the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page
- Check3 days agoChange DetectedThe site revision label in the footer changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAn NIH-wide notice about changing terminology appears above the page, and the site revision number is updated from v3.7.1 to v3.7.2. The study record area continues to show a 403 error.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision label changes from `v3.7.0` to `v3.7.1` on the 403 error page.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating an access restriction rather than actual study data content. This change appears to reflect a access control issue rather than an update to the study information.SummaryDifference21%

- Check52 days agoChange DetectedThe revision tag updated from v3.6.6 to v3.7.0, signaling a backend update. This change does not modify the study content or the data presented on the page.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now shows a new Revision: v3.6.6, replacing the previous Revision: v3.6.5. This appears to be a minor software version update with no visible changes to the study content or navigation.SummaryDifference0.0%

Stay in the know with updates to Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.